• Return to Headlines

Uptrend Call Working As Array Biopharma Stock Rises 96.3% (ARRY)

By David Diaz

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 10 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

Over the past year, Array Biopharma has traded in a range of $20.72 to $47.98 and is now at $47.85, 131% above that low. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

Array BioPharma Inc. operates as a discovery research company creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Array Biopharma shares.

Log in and add Array Biopharma (ARRY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights Array BioPharma

Ticker(s): ARRY